Arginine Vasopressin in Advanced Vasodilatory Shock

DOI Web Site 被引用文献13件
  • Martin W. Dünser
    From the Division of General and Surgical Intensive Care Medicine, Department of Anaesthesia and Critical Care Medicine (M.W.D., A.J.M., H.K., G.S., W.P., B.F., W.R.H.), and Department of Medical Biostatistics (H.U.), The Leopold Franzens University of Innsbruck, Austria.
  • Andreas J. Mayr
    From the Division of General and Surgical Intensive Care Medicine, Department of Anaesthesia and Critical Care Medicine (M.W.D., A.J.M., H.K., G.S., W.P., B.F., W.R.H.), and Department of Medical Biostatistics (H.U.), The Leopold Franzens University of Innsbruck, Austria.
  • Hanno Ulmer
    From the Division of General and Surgical Intensive Care Medicine, Department of Anaesthesia and Critical Care Medicine (M.W.D., A.J.M., H.K., G.S., W.P., B.F., W.R.H.), and Department of Medical Biostatistics (H.U.), The Leopold Franzens University of Innsbruck, Austria.
  • Hans Knotzer
    From the Division of General and Surgical Intensive Care Medicine, Department of Anaesthesia and Critical Care Medicine (M.W.D., A.J.M., H.K., G.S., W.P., B.F., W.R.H.), and Department of Medical Biostatistics (H.U.), The Leopold Franzens University of Innsbruck, Austria.
  • Günther Sumann
    From the Division of General and Surgical Intensive Care Medicine, Department of Anaesthesia and Critical Care Medicine (M.W.D., A.J.M., H.K., G.S., W.P., B.F., W.R.H.), and Department of Medical Biostatistics (H.U.), The Leopold Franzens University of Innsbruck, Austria.
  • Werner Pajk
    From the Division of General and Surgical Intensive Care Medicine, Department of Anaesthesia and Critical Care Medicine (M.W.D., A.J.M., H.K., G.S., W.P., B.F., W.R.H.), and Department of Medical Biostatistics (H.U.), The Leopold Franzens University of Innsbruck, Austria.
  • Barbara Friesenecker
    From the Division of General and Surgical Intensive Care Medicine, Department of Anaesthesia and Critical Care Medicine (M.W.D., A.J.M., H.K., G.S., W.P., B.F., W.R.H.), and Department of Medical Biostatistics (H.U.), The Leopold Franzens University of Innsbruck, Austria.
  • Walter R. Hasibeder
    From the Division of General and Surgical Intensive Care Medicine, Department of Anaesthesia and Critical Care Medicine (M.W.D., A.J.M., H.K., G.S., W.P., B.F., W.R.H.), and Department of Medical Biostatistics (H.U.), The Leopold Franzens University of Innsbruck, Austria.

書誌事項

タイトル別名
  • A Prospective, Randomized, Controlled Study

抄録

<jats:p> <jats:bold> <jats:italic>Background—</jats:italic> </jats:bold> Vasodilatory shock is a potentially lethal complication of severe disease in critically ill patients. Currently, catecholamines are the most widely used vasopressor agents to support blood pressure, but loss of catecholamine pressor effects is a well-known clinical dilemma. Arginine vasopressin (AVP) has recently been shown to be a potent vasopressor agent to stabilize cardiocirculatory function even in patients with catecholamine-resistant vasodilatory shock. </jats:p> <jats:p> <jats:bold> <jats:italic>Methods and Results—</jats:italic> </jats:bold> Forty-eight patients with catecholamine-resistant vasodilatory shock were prospectively randomized to receive a combined infusion of AVP and norepinephrine (NE) or NE infusion alone. In AVP patients, AVP was infused at a constant rate of 4 U/h. Hemodynamic, acid/base, single-organ, and tonometrically derived gastric variables were reported before the study and 1, 12, 24, and 48 hours after study entry. For statistical analysis, a mixed-effects model was used. AVP patients had significantly lower heart rate, NE requirements, and incidence of new-onset tachyarrhythmias than NE patients. Mean arterial pressure, cardiac index, stroke volume index, and left ventricular stroke work index were significantly higher in AVP patients. NE patients developed significantly more new-onset tachyarrhythmias than AVP patients (54.3% versus 8.3%). Gastrointestinal perfusion as assessed by gastric tonometry was better preserved in AVP-treated patients. Total bilirubin concentrations were significantly higher in AVP patients. </jats:p> <jats:p> <jats:bold> <jats:italic>Conclusions—</jats:italic> </jats:bold> The combined infusion of AVP and NE proved to be superior to infusion of NE alone in the treatment of cardiocirculatory failure in catecholamine-resistant vasodilatory shock. </jats:p>

収録刊行物

  • Circulation

    Circulation 107 (18), 2313-2319, 2003-05-13

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (13)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ